Only the IgM antibody against ACHRG showed an increase from baseline to time of toxicity among pneumonitis cases (p=0.03, FDR= 0.48) and was also elevated during pneumonitis event as compared to 12-week “control” samples (p=0.00018, FDR= 0.012) (Figure 3). Here, CHRNG is linked to pneumonitis.